Semaglutide found to reduce risk of kidney disease and death Popular diabetes medication semaglutide has been found to prevent kidney failure and reduce deaths in people with type 2 diabetes and chronic kidney disease. Semaglutide, more widely known by brand names Ozempic and Wegovy, significantly reduces the risk of kidney failure, substantial loss of kidney function and death from kidney or cardiovascular causes, an international clinical trial has shown.
https://www.scimex.org/newsfee....d/semaglutide-found-